Cargando…
A decade of CD4+ chimeric antigen receptor T-cell evolution in two chronic lymphocytic leukemia patients: were chronic lymphocytic leukemia cells present?
On Feb 2, 2022, Nature published the paper titled “Decade-long leukemia remissions with the persistence of CD4+ CAR T-cells” (Nature. 2022;602:503–9. doi: 10.1038/s41586-021-04390-6). According to the results presented, it could be argued that “chimeric antigen receptor (CAR) T-cells can actually cu...
Autores principales: | Bouzianas, Dimitrios, Bouziana, Stella |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Open Exploration Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10645517/ https://www.ncbi.nlm.nih.gov/pubmed/37970204 http://dx.doi.org/10.37349/etat.2023.00186 |
Ejemplares similares
-
Chimeric Antigen Receptor T Cells Targeting CD19 and Ibrutinib for Chronic Lymphocytic Leukemia
por: Delgado, Julio, et al.
Publicado: (2019) -
Chimeric antigen receptor-modified T cell therapy in chronic lymphocytic leukemia
por: Zou, Yixin, et al.
Publicado: (2018) -
Highlights: B-chronic lymphocytic leukemia: Current diagnostic characteristics of and treatments for chronic lymphocytic leukemia in Japan
por: Aoki, Sadao
Publicado: (2020) -
Lipids and Their Effects in Chronic Lymphocytic Leukemia
por: Friedman, Daphne R.
Publicado: (2016) -
Performance of anti-CD19 chimeric antigen receptor T cells in genetically defined classes of chronic lymphocytic leukemia
por: Mancikova, Veronika, et al.
Publicado: (2020)